Studio LSD Limited (NSE:STUDIOLSD)
India · Delayed Price · Currency is INR 8.50
-0.10 (-1.16%)
At close: Oct 23, 2026
Studio LSD Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 721.13 | 1,045 | 1,025 | 466.77 | 146.12 | |
Revenue Growth | -30.98% | 1.95% | 119.54% | 219.45% | 159.77% |
Cost of Revenue | 569.53 | 694.03 | 715.36 | 350.6 | 104.61 |
Gross Profit | 151.6 | 350.75 | 309.39 | 116.17 | 41.51 |
Selling, General & Admin | 63.07 | 97.61 | 68 | 32.17 | 31.68 |
Other Operating Expenses | 113.58 | 97.57 | 93.13 | 46.56 | 0.1 |
Operating Expenses | 181.1 | 197.86 | 162.9 | 79.17 | 32.1 |
Operating Income | -29.5 | 152.89 | 146.5 | 37 | 9.41 |
Interest Expense | -0.21 | -0 | -0.02 | -0.95 | -0.4 |
Interest & Investment Income | 11.23 | 2.39 | 0.17 | 0.29 | 0.03 |
Currency Exchange Gain (Loss) | 0.07 | -0.11 | - | - | - |
Other Non Operating Income (Expenses) | 0.98 | 0.67 | -0.01 | 0.03 | -0.01 |
EBT Excluding Unusual Items | -17.42 | 155.84 | 146.64 | 36.37 | 9.03 |
Gain (Loss) on Sale of Investments | 9.83 | 2.22 | - | - | - |
Gain (Loss) on Sale of Assets | -0.06 | -0.31 | -0.01 | - | - |
Pretax Income | -7.66 | 157.75 | 146.63 | 36.37 | 9.03 |
Income Tax Expense | 2.35 | 40.09 | 37.59 | 8.42 | -0.06 |
Net Income | -10 | 117.66 | 109.04 | 27.95 | 9.1 |
Net Income to Common | -10 | 117.66 | 109.04 | 27.95 | 9.1 |
Net Income Growth | - | 7.91% | 290.11% | 207.23% | - |
Shares Outstanding (Basic) | 48 | 41 | 41 | 41 | 41 |
Shares Outstanding (Diluted) | 48 | 41 | 41 | 41 | 41 |
Shares Change | 16.44% | 0.01% | - | - | 19.96% |
EPS (Basic) | -0.21 | 2.88 | 2.67 | 0.68 | 0.22 |
EPS (Diluted) | -0.21 | 2.88 | 2.67 | 0.68 | 0.22 |
EPS Growth | - | 7.90% | 292.16% | 209.09% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -223.87 | 55.59 | 68.95 | 7.75 | 5.32 |
Free Cash Flow Per Share | -4.70 | 1.36 | 1.69 | 0.19 | 0.13 |
Gross Margin | 21.02% | 33.57% | 30.19% | 24.89% | 28.41% |
Operating Margin | -4.09% | 14.63% | 14.30% | 7.93% | 6.44% |
Profit Margin | -1.39% | 11.26% | 10.64% | 5.99% | 6.23% |
Free Cash Flow Margin | -31.04% | 5.32% | 6.73% | 1.66% | 3.64% |
EBITDA | -26.21 | 155.56 | 148.26 | 37.44 | 9.73 |
EBITDA Margin | -3.63% | 14.89% | 14.47% | 8.02% | 6.66% |
D&A For EBITDA | 3.29 | 2.67 | 1.76 | 0.45 | 0.32 |
EBIT | -29.5 | 152.89 | 146.5 | 37 | 9.41 |
EBIT Margin | -4.09% | 14.63% | 14.30% | 7.93% | 6.44% |
Effective Tax Rate | - | 25.41% | 25.64% | 23.15% | - |
Revenue as Reported | 743.31 | 1,050 | 1,025 | 467.12 | 146.15 |